Ekarpen, a private equity firm backed by the government of the Basque Country, and Basque lender BBK have led a €9m funding round for Spanish biotechnology company Oncomatryx.
GP takes a minority stake in the IT service, while the management team remain on board
Existing investors E.Ventures and Heartcore also participate in the funding round
Transaction involves four remaining assets, including Genesys, eDreams and Asia Broadcast Satellite
Existing investors Velocity Capital, Industrifonden and Frumtak also participate